Clinical Trial

Fast-Her: Fasting Effects on Breast Cancer Treatment

Name: Fast-Her: Fasting Effects on Breast Cancer Treatment — clinical trial record (NCT07624617)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

We hypothesize that promoting a fasting state will strengthen the anti-cancer effects of PI3K inhibitors in metastatic breast cancer (MBC) treatment. The primary objective of this study is to assess acceptability of prolonged fasting in this population.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-09

Trial Details

NCT Number	NCT07624617
Lead Sponsor	University of Minnesota
Conditions	Metastatic Breast Cancer
Enrollment	15 participants
Start Date	2026-05-18
Primary Completion	2027-07-01 (estimated)
Study Completion	2027-07-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-13